| Jeffrey Bland, PhD, President and Chief Science Officer, Metagenics, Inc. and Chairman of the Board, The Institute for Functional Medicine
This presentation will review a strategic approach toward the reduction of risk to the major age-related chronic diseases and the increase of the health span. This approach will be described in terms of current understanding of the molecular and cellular changes associated with premature biological aging. Emphasis will be placed on mitochondrial function, insulin signaling, inflammatory patterns, and the gastrointestinal immune system as the focus for improvement of the health span. This discussion will highlight recent published basic and clinical science studies. The outcome with people will be described through representative clinical case histories and outcome studies. |